Eton Pharmaceuticals (ETON) Debt to Equity (2020 - 2025)
Historic Debt to Equity for Eton Pharmaceuticals (ETON) over the last 6 years, with Q3 2025 value amounting to $1.31.
- Eton Pharmaceuticals' Debt to Equity rose 40872.3% to $1.31 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.31, marking a year-over-year increase of 40872.3%. This contributed to the annual value of $1.22 for FY2024, which is 25106.95% up from last year.
- According to the latest figures from Q3 2025, Eton Pharmaceuticals' Debt to Equity is $1.31, which was up 40872.3% from $1.26 recorded in Q2 2025.
- In the past 5 years, Eton Pharmaceuticals' Debt to Equity ranged from a high of $1.31 in Q3 2025 and a low of $0.02 during Q1 2021
- Its 5-year average for Debt to Equity is $0.34, with a median of $0.09 in 2023.
- Per our database at Business Quant, Eton Pharmaceuticals' Debt to Equity crashed by 2389.89% in 2022 and then skyrocketed by 40872.3% in 2025.
- Quarter analysis of 5 years shows Eton Pharmaceuticals' Debt to Equity stood at $0.08 in 2021, then decreased by 1.79% to $0.08 in 2022, then skyrocketed by 340.08% to $0.35 in 2023, then surged by 251.07% to $1.22 in 2024, then grew by 7.6% to $1.31 in 2025.
- Its last three reported values are $1.31 in Q3 2025, $1.26 for Q2 2025, and $1.22 during Q4 2024.